Amrize Delivers Strong Free Cash Flow in 2025; Shareholder Return Plan Proposed
Performance Highlights and 2026 Guidance
- Revenues up 0.9% to $11.8 billion on infrastructure demand and improving commercial market
- Net income of $1.2 billion and Adjusted EBITDA of $3.0 billion
- Strong Operating Cash Flow of $2.2 billion and Free Cash Flow of $1.5 billion
- Building Materials Revenue growth continued in fourth quarter with strong margin expansion
- Strong commercial repair and refurbishment trends in Building Envelope; softer residential demand
- 2026 guidance: Revenues +4-6%, Adjusted EBITDA +8-11%
Shareholder Return Plan
- Share Repurchase Authorization of $1.0 billion1
- Special one-time dividend of $0.44 per share2,3
- Annual ordinary dividend of $0.44 per share2,4 to be paid in quarterly installments
CHICAGO & ZUG, Switzerland–(BUSINESS WIRE)–
Amrize (AMRZ) announced today its fourth quarter and full year 2025 financial results.
Jan Jenisch, Chairman and CEO: “2025 was a milestone year for Amrize as we completed our spin-off, delivered for our customers and set the foundation for our long-term, profitable growth. I thank our 19,000 empowered teammates who are serving our customers across North America as the partner of choice for their most important building projects.
We increased revenues to $11.8 billion and delivered $3.0 billion of Adjusted EBITDA driven by infrastructure demand and an improving commercial market. As we closed the year, we saw growing customer demand in cement and aggregates, as well as continued positive pricing. Our Building Envelope business was affected by the soft residential roofing market, while commercial repair and refurbishment remained resilient.
We generated strong Free Cash Flow on the year and achieved a Net Leverage Ratio of 1.1x. Our strong cash conversion and balance sheet provide the flexibility and firepower to fuel our growth and return cash to our shareholders.
We invested $788 million in CapEx in 2025, and plan to increase these investments to $900 million in 2026 to accelerate our growth. We are also ramping up our value-accretive M&A to expand our footprint in the most attractive markets, demonstrated recently with our agreement to acquire PB Materials, the leading aggregates business in high-growth West Texas.
Delivering shareholder return, our Board has authorized a $1.0 billion share repurchase program, and proposes a special one time dividend as well as an annual ordinary dividend.
We are delivering on our commitment to invest for growth and create value for all stakeholders. We are well positioned in our $200 billion addressable market and have set our 2026 guidance reflecting accelerating customer demand and profitable growth.”
|
___________________________ 1 Amrize Board of Directors approved a share repurchase authorization for up to $1.0 billion, with a 12-month expiration, pending approval of the 2025 financial statements at the Annual General Meeting. |
|
2 Dividends will be paid out of legal capital reserves from tax capital contributions and are not subject to Swiss withholding tax. |
|
3 Amrize Board of Directors proposes a special one-time dividend of $0.44 per share, to be paid following shareholder approval at the Annual General Meeting. |
|
4 Amrize Board of Directors proposes an annual ordinary dividend of $0.44 per share, to be paid in up to four quarterly installments at the discretion of the Board, following shareholder approval at the Annual General Meeting. |
Shareholder Return Plan
The Board of Directors has approved a $1.0 billion share repurchase program, pending approval of the 2025 financial statements at the AGM, with a 12-month expiration.
The Board of Directors also proposes a special, one-time dividend of $0.44 per share, payable following approval by shareholders at the AGM, as well as a $0.44 ordinary annual dividend per share, payable in quarterly installments, at the discretion of the Board.
Dividends will be paid out of capital contribution reserves and are not subject to Swiss withholding tax.
Full Year 2026 Financial Guidance5
Amrize has established an efficient capital structure and operating model. 2025 Corporate costs were $210 million versus guidance of $300 to $320 million6. Net interest expense was $413 million versus $512 million in 2024 and the effective tax rate was 21.8% versus guidance of 22% to 24%. Cash and cash equivalents as of December 31, 2025 were $1,922 million and Net Debt7 was $3,347 million. The Net Leverage Ratio8 as of December 31, 2025 was 1.1x, compared to 1.7x as of September 30, 2025.
This positions the company to continue generating growth and returns. Amrize has set 2026 guidance reflecting accelerating customer demand and profitable growth. In Building Materials, volumes and pricing are expected to be growth contributors with low single-digit percentage growth in cement pricing and mid-single-digit percentage growth in aggregates pricing. In Building Envelope, Amrize expects low-single digit growth in commercial roofing volumes and flat volumes in residential roofing with improvement in the second half of the year.
Based on these drivers, Amrize is providing the following financial guidance for full year 2026:
|
Revenues |
$12.29 billion to $12.52 billion |
+4% to +6% |
|
|
Adjusted EBITDA |
$3.25 billion to $3.34 billion |
+ 8% to +11% |
The Company’s 2026 financial guidance includes the following underlying assumptions:
|
Capital Expenditures |
$900 million |
||
|
Interest Expense, Net |
$340 million |
||
|
Effective Tax Rate |
21% – 23% |
||
|
Corporate Costs |
$200 million |
ASPIRE Program Update
Amrize launched its ASPIRE program in 2025 to accelerate synergies and profitable growth. Leveraging its scale across 1,000 sites and two business segments, the company is optimizing third party spending and driving efficiencies in its operational footprint and logistics network.
Amrize realized initial savings in the fourth quarter and the company is now targeting 70 basis points of margin expansion through ASPIRE in 2026 and is on track to achieve more than $250 million in synergies through 2028.
|
___________________________ 5 Amrize (Company) provides forward-looking guidance regarding Adjusted EBITDA. The Company cannot, without unreasonable effort, forecast certain adjusted items excluded from comparable U.S. GAAP financial measures. These items include Acquisition and integration-related costs, Litigation-related costs, Loss on impairments, Restructuring and other costs, Spin-off and separation-related costs, Other non-operating (expense) income, net, and Income from equity method investments., that are difficult to predict in advance to include in a U.S. GAAP estimate. For the same reasons, the Company is unable to address the probable significance of the items. |
|
6 FY 2025 corporate costs compared to the quarterly run rate of $75-$80 million corporate cost provided during Q2 2025. |
|
7 Net Debt represents a non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
|
8 Net Leverage Ratio represents a non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
Amrize Consolidated Results (Unaudited)
|
|
For the three months ended |
|
For the years ended |
||||||||||||||
|
$ in millions, except per share data |
|
2025 |
|
|
2024 |
|
% Change |
|
|
2025 |
|
|
2024 |
|
% Change |
||
|
Revenues |
$ |
2,839 |
|
$ |
2,849 |
|
(0.4 |
%) |
|
$ |
11,815 |
|
$ |
11,704 |
|
0.9 |
% |
|
Net income |
$ |
298 |
|
$ |
292 |
|
+2.1% |
|
$ |
1,182 |
|
$ |
1,273 |
|
(7.1 |
%) |
|
|
Net income margin |
|
10.5 |
% |
|
10.2 |
% |
+30bps |
|
|
10.0 |
% |
|
10.9 |
% |
(90bps) |
||
|
|
|
|
|
|
|
|
|
||||||||||
|
Adjusted EBITDA9 |
$ |
779 |
|
$ |
791 |
|
(1.5 |
%) |
|
$ |
3,007 |
|
$ |
3,181 |
|
(5.5 |
%) |
|
Adjusted EBITDA Margin10 |
|
27.4 |
% |
|
27.8 |
% |
(40bps) |
|
|
25.5 |
% |
|
27.2 |
% |
(170bps) |
||
|
Diluted Earnings per Share (EPS) |
$ |
0.54 |
|
$ |
0.53 |
|
+1.9% |
|
$ |
2.14 |
|
$ |
2.30 |
|
(7.0 |
%) |
|
|
Adjusted Diluted EPS11 |
$ |
0.62 |
|
$ |
0.57 |
|
+8.8% |
|
$ |
2.40 |
|
$ |
2.44 |
|
(1.6 |
%) |
|
Revenues were $2,839 million in the fourth quarter of 2025 compared to $2,849 million in 2024. Revenues were 0.4% lower in the quarter, reflecting continued infrastructure spend, an improving commercial market and the soft residential roofing market.
Adjusted EBITDA was $779 million for the fourth quarter of 2025 compared with $791 million in 2024. Adjusted EBITDA was driven by higher volumes and continued aggregates pricing growth in the Building Materials segment, offset by lower residential roofing volumes in the Building Envelope segment.
Net income was $298 million for the fourth quarter of 2025, or $0.54 Diluted EPS, compared with Net income of $292 million, or $0.53 Diluted EPS, in 2024. Net income was $1,182 million for the full year 2025, or $2.14 Diluted EPS, compared with Net income of $1,273 million, or $2.30 Diluted EPS, in 2024.
Adjusted Diluted EPS for the fourth quarter of 2025 was $0.62 compared to $0.57 in 2024. Adjusted Diluted EPS for the full year 2025 was $2.40 compared to $2.44 in 2024.
|
___________________________ 9 Adjusted EBITDA represents a Non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
|
10 Adjusted EBITDA Margin represents a Non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
|
11 Adjusted Diluted EPS represents a Non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
Amrize Building Materials Results (Unaudited)
|
|
For the three months ended |
|
For the years ended |
||||||||||||||
|
$ in millions |
|
2025 |
|
|
2024 |
|
% Change |
|
|
2025 |
|
|
2024 |
|
% Change |
||
|
Revenues |
$ |
2,161 |
|
$ |
2,080 |
|
3.9 |
% |
|
$ |
8,514 |
|
$ |
8,329 |
|
2.2 |
% |
|
Segment Adjusted EBITDA12 |
$ |
705 |
|
$ |
666 |
|
5.9 |
% |
|
$ |
2,485 |
|
$ |
2,552 |
|
(2.6 |
%) |
|
Segment Adjusted EBITDA Margin13 |
|
32.6 |
% |
|
32.0 |
% |
60bps |
|
|
29.2 |
% |
|
30.6 |
% |
(140bps) |
||
|
Volumes |
For the three months ended |
|
For the years ended |
||||||
|
in millions |
2025 |
2024 |
% Change |
|
2025 |
2024 |
% Change |
||
|
Cement – tons sold14 |
5.7 |
5.5 |
3.6 |
% |
|
22.4 |
22.6 |
(0.9 |
%) |
|
Aggregates – tons sold15 |
30.9 |
30.0 |
3.0 |
% |
|
118.9 |
119.8 |
(0.8 |
%) |
|
Average Selling Price |
For the three months ended December 31, |
||||||||||
|
$ per ton |
|
2025 |
|
2024 |
% Change |
|
Constant |
% Change Constant Currency |
|||
|
Cement – price per ton9 |
$ |
167.52 |
$ |
167.80 |
(0.2 |
%) |
|
$ |
166.51 |
(0.8 |
%) |
|
Aggregates – price per ton10 |
$ |
13.79 |
$ |
13.27 |
3.9 |
% |
|
$ |
13.77 |
3.8 |
% |
|
|
|
|
|
|
|
|
|||||
|
|
For the years ended December 31, |
||||||||||
|
$ per ton |
|
2025 |
|
2024 |
% Change |
|
Constant |
% Change Constant |
|||
|
Cement – price per ton |
$ |
170.05 |
$ |
170.21 |
(0.1 |
%) |
|
$ |
170.65 |
0.3 |
% |
|
Aggregates – price per ton |
$ |
14.06 |
$ |
13.35 |
5.3 |
% |
|
$ |
14.16 |
6.1 |
% |
Building Materials Revenues were $2,161 million in the fourth quarter of 2025 compared to $2,080 million in 2024. Revenue growth of 3.9% in the fourth quarter of 2025 was driven by higher volumes and continued aggregates pricing growth. Cement volumes were up 3.6% with pricing down 0.8% coupled with increased aggregates volumes of 3.0% with freight-adjusted pricing up 3.8%.
Fourth quarter 2025 Segment Adjusted EBITDA for the Building Materials segment was $705 million, compared to $666 million in 2024. The increase was mainly attributable to volume growth, aggregates pricing, production efficiency and ASPIRE savings.
The company is executing on its strategy of investing for growth through CapEx and M&A in the most attractive markets. In the fourth quarter, Building Materials completed a 660,000 ton capacity expansion at its Ste. Genevieve cement plant, North America’s largest and market leading plant. In January, Amrize announced an agreement to acquire PB Materials, expanding its aggregates business into high-growth West Texas. The company expects the acquisition to close in the first quarter.
|
___________________________ 12 Segment Adjusted EBITDA represents a Non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
|
13 Segment Adjusted EBITDA Margin represents a Non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
|
14 Cement volume and pricing figures presented above exclude trading. |
|
15 Aggregates pricing figures presented above are freight adjusted, excluding freight revenues. |
|
16 Constant Currency reflects price adjusted to prior period foreign exchange rates. |
Amrize Building Envelope Results (Unaudited)
|
|
For the three months ended |
|
For the years ended |
||||||||||||||
|
$ in millions |
|
2025 |
|
|
2024 |
|
% Change |
|
|
2025 |
|
|
2024 |
|
% Change |
||
|
Revenues |
$ |
678 |
|
$ |
769 |
|
(11.8 |
%) |
|
$ |
3,301 |
|
$ |
3,375 |
|
(2.2 |
%) |
|
Segment Adjusted EBITDA |
$ |
130 |
|
$ |
170 |
|
(23.5 |
%) |
|
$ |
732 |
|
$ |
770 |
|
(4.9 |
%) |
|
Segment Adjusted EBITDA Margin |
|
19.2 |
% |
|
22.1 |
% |
(290bps) |
|
|
22.2 |
% |
|
22.8 |
% |
(60bps) |
||
Building Envelope Revenues were $678 million for the fourth quarter of 2025, compared to $769 million in 2024. This decrease was primarily due to softer residential roofing demand, partially offset by strong commercial repair and refurbishment revenues.
Fourth quarter 2025 Segment Adjusted EBITDA for the Building Envelope segment was $130 million, compared to $170 million in 2024. Lower Adjusted EBITDA was mainly due to lower residential roofing volumes and an $8 million increase in warranty provisions, which was partially offset by an improvement in commercial roofing margin on resilient repair and refurbishment demand.
The company is on track to commission a new state-of-the-art Malarkey shingle factory in Franklin, Indiana by the end of 2026 to increase production and expand market share in the attractive Midwest and Eastern markets.
Amrize Cash Flow and Debt
For the year ended December 31, 2025, cash provided by operating activities was $2,208 million as compared to $2,282 million for the year ended December 31, 2024. Free Cash Flow17 was $1,463 million for the year ended December 31, 2025 compared to $1,733 million for the year ended December 31, 2024, a decrease of $270 million.
The decrease in cash provided by operating activities of $74 million was primarily driven by lower net income of $91 million and changes to net working capital.
Gross Debt as of December 31, 2025 was $5,269 million. Cash and cash equivalents were $1,922 million, resulting in a decrease in Net Debt18 to $3,347 million. The Net Leverage Ratio19 as of December 31, 2025 was 1.1x, compared to 1.7x as of September 30, 2025.
|
___________________________ 17 Free Cash Flow represents a non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
|
18 Net Debt represents a non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
|
19 Net Leverage Ratio represents a non-GAAP measure, which is defined on page 7 and reconciled on pages 13-15. |
About Amrize
Amrize (NYSE: AMRZ) is building North America, as the partner of choice for professional builders with advanced branded solutions from foundation to rooftop. With over 1,000 sites and a highly efficient distribution network, we deliver for our customers in every U.S. state and Canadian province. Our 19,000 teammates uniquely serve every construction market from infrastructure, commercial and residential to new build, repair and refurbishment. Amrize achieved $11.8 billion in revenues in 2025 and is listed on the New York Stock Exchange and the SIX Swiss Exchange. Learn more at www.amrize.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this presentation may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act, such as statements regarding expected cost savings, future financial targets, business strategies, management’s views with respect to future events and financial performance, and the assumptions underlying such expected cost savings, targets, strategies, and statements. Forward-looking statements include those preceded by, followed by or that include the words such as “may,” “will,” “could,” “should,” “might,” “projects,” “expects,” “believes,” “anticipates,” “intends,” “plans,” “continue,” “estimate,” or “pursue,” or similar expressions. Such forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from historical experience or from future results expressed or implied by such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the effect of political, economic and market conditions and geopolitical events; the level of demand in the construction industry; the cyclicality of the industries and businesses in which our customers operate; changes in the cost and/or availability of raw materials required to run our business; energy and fuel costs; adverse weather conditions and natural disasters; the logistical and other challenges inherent in our operations; the actions and initiatives of current and potential competitors; the level and volatility of, interest rates and other market indices; the ability of Amrize to realize the expected significant synergies for our acquisitions; the ability of Amrize to achieve margin expansion goals; the ability of Amrize to maintain satisfactory credit ratings; the outcome of pending litigation or future litigation; the impact of current, pending and future legislation and regulation; factors related to the failure of Amrize to achieve some or all of the expected strategic benefits or opportunities expected from the separation from Holcim Ltd (“Holcim”); material costs and expenses as a result of the separation from Holcim; our limited history operating as an independent, publicly traded company; our obligation to indemnify Holcim pursuant to the agreements entered into connection with the separation and the risk Holcim may not fulfill any obligations to indemnify Amrize under such agreements; that under applicable tax law, Amrize may be liable for certain tax liabilities of Holcim following the separation if Holcim were to fail to pay such taxes; the fact that Amrize may receive worse commercial terms from third-parties for services it used to receive from Holcim prior to the separation; the fact that certain of Amrize’s executive officers and directors may have actual or potential conflicts of interest because of their previous positions at Holcim; and potential difficulties in maintaining relationships with key personnel; and other factors which can be found in Amrize’s media releases and Amrize’s filings with the SEC. These statements are not guarantees of future performance and are subject to future events, risks and uncertainties – many of which are beyond our control, dependent on the actions of third parties, or currently unknown to us – as well as potentially inaccurate assumptions that could cause actual results to differ materially from our historical experience and our expectations and projections.
Any forward-looking statement speaks only as of the date on which it is made. We do not undertake or assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. You are advised, however, to review any further disclosures we make on related subjects in our filings with the Securities and Exchange Commission and in our other public statements.
FINANCIAL MEASURES AND DEFINITIONS
Adjusted EBITDA is defined as Segment Adjusted EBITDA including unallocated corporate costs.
Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Revenues.
Adjusted Diluted EPS is defined as Diluted Earnings per share attributable to the Company, excluding the impact of Acquisition and integration-related costs, Litigation-related costs, Loss on impairments, Restructuring and other costs, Spin-off and separation-related costs.
Capital Expenditures, Net includes purchases of property, plant and equipment, proceeds from property and casualty insurance income, proceeds from land expropriation and proceeds from disposals of long-lived assets.
EBITDA is defined as Net income, excluding Depreciation, depletion, accretion and amortization, Interest expense, net and Income tax expense.
EBITDA Margin is defined as EBITDA divided by Revenues.
Free Cash Flow is defined as Net cash provided by operating activities less Capital Expenditures, Net.
Net Debt is defined as the sum of Short-term borrowings, Long-term debt and Current portion of long-term debt minus Cash and cash equivalents.
Net Leverage Ratio is defined as Net Debt divided by trailing 12 months Adjusted EBITDA.
Net Working Capital is defined as the change in accounts receivables, inventory, and accounts payable.
Segment Adjusted EBITDA is defined as Net income, and excludes the impact of Depreciation, depletion, accretion and amortization, Interest expense, net, Income tax expense, Acquisition and integration-related costs, Litigation-related costs, Loss on impairments, Restructuring and other costs, Spin-off and separation-related costs, Other non-operating (expense) income, net, Income from equity method investments, and unallocated corporate costs.
Segment Adjusted EBITDA Margin is defined as Segment Adjusted EBITDA divided by Revenues.
This media release contains certain financial measures of historical performance and financial positions that are not prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). Non-GAAP financial measures are reconciled to the most comparable U.S. GAAP measures in the schedules attached hereto. Adjusted financial measures are Non-GAAP measures and exclude adjusting items as described and reconciled to comparable U.S. GAAP financial measures in the Reconciliation of U.S. GAAP to Non-GAAP Financial Measures contained in this Media Release.
We believe these adjusted financial measures facilitate analysis and comparisons of our ongoing business operations because they exclude items that may not be indicative of, or are unrelated to, the Company’s and our business segments’ core operating performance, and may assist investors with comparisons to prior periods and assessing trends in our underlying businesses. These adjustments are consistent with how management views our businesses. Management uses these Non-GAAP financial measures in making financial, operating and planning decisions and evaluating Amrize’s and each business segment’s ongoing performance.
Our Non-GAAP financial measures are intended to supplement and should be read together with, and are not an alternative or substitute for, and should not be considered superior to, our reported financial results. Accordingly, users of our financial statements should not place undue reliance on these Non-GAAP financial measures. Because Non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies’ Non-GAAP financial measures having the same or similar names. As required by SEC rules, the tables on pages 13-15 below present a reconciliation of our presented Non-GAAP financial measures to the most directly comparable U.S. GAAP measures.
|
Amrize Ltd |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
U.S. GAAP and Adjusted Measures Fourth Quarter 2025 (Unaudited) |
|
|
|
|
|
|
||||||||||||
|
($ in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
For the three months ended |
|
For the years ended |
||||||||||||||
|
|
|
2025 |
|
|
2024 |
|
|
% Change |
|
2025 |
|
|
2024 |
|
|
% Change |
||
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Building Materials |
$ |
2,161 |
|
$ |
2,080 |
|
|
3.9 |
% |
$ |
8,514 |
|
$ |
8,329 |
|
|
2.2 |
% |
|
Building Envelope |
|
678 |
|
|
769 |
|
|
(11.8 |
%) |
|
3,301 |
|
|
3,375 |
|
|
(2.2 |
%) |
|
Total Revenues |
$ |
2,839 |
|
$ |
2,849 |
|
|
(0.4 |
%) |
$ |
11,815 |
|
$ |
11,704 |
|
|
0.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Segment Adjusted EBITDA: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Building Materials |
$ |
705 |
|
$ |
666 |
|
|
5.9 |
% |
$ |
2,485 |
|
$ |
2,552 |
|
|
(2.6 |
%) |
|
Building Envelope |
|
130 |
|
|
170 |
|
|
(23.5 |
%) |
|
732 |
|
|
770 |
|
|
(4.9 |
%) |
|
Total Segment Adjusted EBITDA |
|
835 |
|
|
836 |
|
|
(0.1 |
%) |
|
3,217 |
|
|
3,322 |
|
|
(3.2 |
%) |
|
Reconciling items * |
|
(52 |
) |
|
(71 |
) |
|
(26.8 |
%) |
|
(172 |
) |
|
(139 |
) |
|
23.7 |
% |
|
Depreciation, depletion, accretion and amortization |
|
(244 |
) |
|
(225 |
) |
|
8.4 |
% |
|
(914 |
) |
|
(889 |
) |
|
2.8 |
% |
|
Unallocated corporate costs |
|
(56 |
) |
|
(45 |
) |
|
24.4 |
% |
|
(210 |
) |
|
(141 |
) |
|
48.9 |
% |
|
Interest income |
|
7 |
|
|
13 |
|
|
(46.2 |
%) |
|
48 |
|
|
35 |
|
|
37.1 |
% |
|
Interest expense |
|
(92 |
) |
|
(141 |
) |
|
(34.8 |
%) |
|
(461 |
) |
|
(547 |
) |
|
(15.7 |
%) |
|
Income tax expense |
|
(100 |
) |
|
(75 |
) |
|
33.3 |
% |
|
(326 |
) |
|
(368 |
) |
|
(11.4 |
%) |
|
Net income |
$ |
298 |
|
$ |
292 |
|
|
2.1 |
% |
$ |
1,182 |
|
$ |
1,273 |
|
|
(7.1 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
* The reconciling items are made up of Acquisition and integration-related costs, Litigation-related costs, Loss on impairments, Restructuring and other costs, Spin-off and separation-related costs, Other non-operating (expense) income, net, and Income from equity method investments. |
||||||||||||||||||
|
Amrize Ltd |
|
|
|
|
|
|
|
|
||||||||
|
Unaudited Condensed Consolidated Statement of Operations |
||||||||||||||||
|
($ in millions, except per share data) |
|
|
|
|
|
|
|
|
||||||||
|
|
|
For the three months ended |
|
For the years ended |
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Revenues |
$ |
|
2,839 |
|
$ |
|
2,849 |
|
$ |
|
11,815 |
|
$ |
|
11,704 |
|
|
Cost of revenues |
|
|
(2,079 |
) |
|
|
(2,072 |
) |
|
|
(8,781 |
) |
|
|
(8,634 |
) |
|
Gross profit |
|
|
760 |
|
|
|
777 |
|
|
|
3,034 |
|
|
|
3,070 |
|
|
Selling, general and administrative expenses |
|
|
(278 |
) |
|
|
(262 |
) |
|
|
(1,128 |
) |
|
|
(944 |
) |
|
Gain on disposal of long-lived assets |
|
|
6 |
|
|
|
22 |
|
|
|
15 |
|
|
|
71 |
|
|
Loss on impairments |
|
|
(13 |
) |
|
|
— |
|
|
|
(15 |
) |
|
|
(2 |
) |
|
Operating income |
|
|
475 |
|
|
|
537 |
|
|
|
1,906 |
|
|
|
2,195 |
|
|
Interest expense, net |
|
|
(85 |
) |
|
|
(128 |
) |
|
|
(413 |
) |
|
|
(512 |
) |
|
Other non-operating income (expense), net |
|
|
2 |
|
|
|
(48 |
) |
|
|
4 |
|
|
|
(55 |
) |
|
Income before income tax expense and income from equity method investments |
|
|
392 |
|
|
|
361 |
|
|
|
1,497 |
|
|
|
1,628 |
|
|
Income tax expense |
|
|
(100 |
) |
|
|
(75 |
) |
|
|
(326 |
) |
|
|
(368 |
) |
|
Income from equity method investments |
|
|
6 |
|
|
|
6 |
|
|
|
11 |
|
|
|
13 |
|
|
Net income |
|
|
298 |
|
|
|
292 |
|
|
|
1,182 |
|
|
|
1,273 |
|
|
Net (income) loss attributable to noncontrolling interests |
|
|
— |
|
|
|
(1 |
) |
|
|
3 |
|
|
|
1 |
|
|
Net income attributable to the Company |
$ |
|
298 |
|
$ |
|
291 |
|
$ |
|
1,185 |
|
$ |
|
1,274 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings per share attributable to the Company: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
|
$ |
0.54 |
|
|
$ |
0.53 |
|
|
$ |
2.14 |
|
|
$ |
2.30 |
|
|
Diluted |
|
$ |
0.54 |
|
|
$ |
0.53 |
|
|
$ |
2.14 |
|
|
$ |
2.30 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted-average number of shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
|
|
553.1 |
|
|
|
553.1 |
|
|
|
553.1 |
|
|
|
553.1 |
|
|
Diluted |
|
|
554.3 |
|
|
|
553.1 |
|
|
|
553.6 |
|
|
|
553.1 |
|
|
Amrize Ltd |
|
|
|
|
|
|
Unaudited Condensed Consolidated Balance Sheets |
|
|
|
|
|
|
($ in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
December 31, 2025 |
|
|
December 31, 2024 |
|
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
$ |
1,922 |
|
$ |
1,585 |
|
Accounts receivable, net |
|
1,120 |
|
|
1,011 |
|
Due from related-party |
|
— |
|
|
58 |
|
Inventories |
|
1,551 |
|
|
1,452 |
|
Related-party notes receivable |
|
— |
|
|
532 |
|
Prepaid expenses and other current assets |
|
88 |
|
|
143 |
|
Total current assets |
|
4,681 |
|
|
4,781 |
|
Property, plant and equipment, net |
|
7,935 |
|
|
7,534 |
|
Goodwill |
|
9,020 |
|
|
8,917 |
|
Intangible assets, net |
|
1,728 |
|
|
1,832 |
|
Operating lease right-of-use assets, net |
|
608 |
|
|
547 |
|
Other noncurrent assets |
|
277 |
|
|
194 |
|
Total Assets |
$ |
24,249 |
|
$ |
23,805 |
|
|
|
|
|
|
|
|
Liabilities and Equity |
|
|
|
|
|
|
Current Liabilities: |
|
|
|
|
|
|
Accounts payable |
$ |
1,538 |
|
$ |
1,285 |
|
Due to related-party |
|
— |
|
|
89 |
|
Current portion of long-term debt |
|
333 |
|
|
5 |
|
Current portion of related-party notes payable |
|
— |
|
|
129 |
|
Operating lease liabilities |
|
136 |
|
|
149 |
|
Other current liabilities |
|
850 |
|
|
893 |
|
Total current liabilities |
|
2,857 |
|
|
2,550 |
|
Long-term debt |
|
4,936 |
|
|
980 |
|
Related-party notes payable |
|
— |
|
|
7,518 |
|
Deferred income tax liabilities |
|
1,048 |
|
|
936 |
|
Noncurrent operating lease liabilities |
|
500 |
|
|
386 |
|
Other noncurrent liabilities |
|
1,654 |
|
|
1,521 |
|
Total Liabilities |
|
10,995 |
|
|
13,891 |
|
Total Equity |
|
13,254 |
|
|
9,914 |
|
Total Liabilities and Equity |
$ |
24,249 |
|
$ |
23,805 |
|
Amrize Ltd |
|
|
|
|
|
||
|
Unaudited Condensed Consolidated Statements of Cash Flow |
|
|
|
|
|
||
|
($ in millions) |
|
|
|
|
|
||
|
|
|
For the years ended |
|||||
|
|
|
2025 |
|
|
|
2024 |
|
|
Cash Flows from Operating Activities: |
|
|
|
|
|
||
|
Net income |
$ |
1,182 |
|
|
$ |
1,273 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
||
|
Depreciation, depletion, accretion and amortization |
|
914 |
|
|
|
889 |
|
|
Loss on impairments |
|
15 |
|
|
|
2 |
|
|
Share-based compensation |
|
14 |
|
|
|
6 |
|
|
Gain on disposal of long-lived assets |
|
(15 |
) |
|
|
(40 |
) |
|
Gain on land expropriation |
|
— |
|
|
|
(31 |
) |
|
Deferred tax expense (benefit) |
|
78 |
|
|
|
(35 |
) |
|
Net periodic benefit cost |
|
12 |
|
|
|
71 |
|
|
Other items, net |
|
134 |
|
|
|
109 |
|
|
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
|
|
|
||
|
Accounts receivable, net |
|
(43 |
) |
|
|
211 |
|
|
Due from related party |
|
49 |
|
|
|
(22 |
) |
|
Inventories |
|
(61 |
) |
|
|
(146 |
) |
|
Accounts payable |
|
190 |
|
|
|
28 |
|
|
Due to related party |
|
(82 |
) |
|
|
(7 |
) |
|
Other assets |
|
45 |
|
|
|
(19 |
) |
|
Other liabilities |
|
(199 |
) |
|
|
48 |
|
|
Defined benefit pension plans and other postretirement benefit plans |
|
(25 |
) |
|
|
(55 |
) |
|
Net cash provided by operating activities |
|
2,208 |
|
|
|
2,282 |
|
|
Cash Flows from Investing Activities: |
|
|
|
|
|
||
|
Purchases of property, plant and equipment |
|
(788 |
) |
|
|
(642 |
) |
|
Acquisitions, net of cash acquired |
|
(86 |
) |
|
|
(249 |
) |
|
Proceeds from disposals of long-lived assets |
|
21 |
|
|
|
61 |
|
|
Proceeds from land expropriation |
|
20 |
|
|
|
32 |
|
|
Proceeds from property and casualty insurance |
|
2 |
|
|
|
— |
|
|
Net decrease (increase) in short-term related-party notes receivable from cash pooling program |
|
522 |
|
|
|
(383 |
) |
|
Other investing activities, net |
|
(52 |
) |
|
|
(27 |
) |
|
Net cash used in investing activities |
|
(361 |
) |
|
|
(1,208 |
) |
|
Cash Flows from Financing Activities: |
|
|
|
|
|
||
|
Transfers to Holcim, net |
|
(91 |
) |
|
|
(304 |
) |
|
Proceeds from issuance of long-term debt, net of discount |
|
3,395 |
|
|
|
— |
|
|
Payments of debt issuance costs |
|
(24 |
) |
|
|
— |
|
|
Net repayments of short-term related-party debt |
|
(129 |
) |
|
|
(101 |
) |
|
Proceeds from debt-for-debt exchange with Holcim |
|
922 |
|
|
|
— |
|
|
Proceeds from issuances of long-term related-party debt |
|
22 |
|
|
|
230 |
|
|
Repayments of long-term related-party debt |
|
(5,541 |
) |
|
|
(272 |
) |
|
Payments of finance lease obligations |
|
(106 |
) |
|
|
(82 |
) |
|
Other financing activities, net |
|
(3 |
) |
|
|
(8 |
) |
|
Net cash used in financing activities |
|
(1,555 |
) |
|
|
(537 |
) |
|
Effect of exchange rate changes on cash and cash equivalents |
|
45 |
|
|
|
(59 |
) |
|
Increase in cash and cash equivalents |
|
337 |
|
|
|
478 |
|
|
Cash and cash equivalents at the beginning of year |
|
1,585 |
|
|
|
1,107 |
|
|
Cash and cash equivalents at the end of year |
$ |
1,922 |
|
|
$ |
1,585 |
|
|
Amrize Ltd |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Reconciliation of Non-GAAP Financial Measures |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Adjusted EBITDA and Adjusted EBITDA Margin (Unaudited) |
|
|
|
|
|
|
|
|
|
||||||
|
($ in millions, except percentage data) |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
For the three months |
|
|
For the years ended |
||||||||||
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
||||
|
Net income |
$ |
298 |
|
|
$ |
292 |
|
|
$ |
1,182 |
|
|
$ |
1,273 |
|
|
Depreciation, depletion, accretion and amortization |
|
244 |
|
|
|
225 |
|
|
|
914 |
|
|
|
889 |
|
|
Interest expense, net |
|
85 |
|
|
|
128 |
|
|
|
413 |
|
|
|
512 |
|
|
Income tax expense |
|
100 |
|
|
|
75 |
|
|
|
326 |
|
|
|
368 |
|
|
EBITDA |
|
727 |
|
|
|
720 |
|
|
|
2,835 |
|
|
|
3,042 |
|
|
Acquisition and integration-related costs(1) |
|
31 |
|
|
|
13 |
|
|
|
64 |
|
|
|
46 |
|
|
Litigation-related costs(2) |
|
2 |
|
|
|
6 |
|
|
|
46 |
|
|
|
9 |
|
|
Loss on impairments(3) |
|
13 |
|
|
|
— |
|
|
|
15 |
|
|
|
2 |
|
|
Restructuring and other costs(4) |
|
6 |
|
|
|
5 |
|
|
|
19 |
|
|
|
16 |
|
|
Spin-off and separation-related costs(5) |
|
8 |
|
|
|
5 |
|
|
|
43 |
|
|
|
24 |
|
|
Other non-operating (income) expense, net(6) |
|
(2 |
) |
|
|
48 |
|
|
|
(4 |
) |
|
|
55 |
|
|
Income from equity method investments |
|
(6 |
) |
|
|
(6 |
) |
|
|
(11 |
) |
|
|
(13 |
) |
|
Adjusted EBITDA |
|
779 |
|
|
|
791 |
|
|
|
3,007 |
|
|
|
3,181 |
|
|
Unallocated corporate costs |
|
56 |
|
|
|
45 |
|
|
|
210 |
|
|
|
141 |
|
|
Total Segment Adjusted EBITDA |
$ |
835 |
|
|
$ |
836 |
|
|
$ |
3,217 |
|
|
$ |
3,322 |
|
|
Building Materials |
$ |
705 |
|
|
$ |
666 |
|
|
$ |
2,485 |
|
|
$ |
2,552 |
|
|
Building Envelope |
$ |
130 |
|
|
$ |
170 |
|
|
$ |
732 |
|
|
$ |
770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net income margin |
|
10.5 |
% |
|
|
10.2 |
% |
|
|
10.0 |
% |
|
|
10.9 |
% |
|
EBITDA Margin |
|
25.6 |
% |
|
|
25.3 |
% |
|
|
24.0 |
% |
|
|
26.0 |
% |
|
Adjusted EBITDA Margin |
|
27.4 |
% |
|
|
27.8 |
% |
|
|
25.5 |
% |
|
|
27.2 |
% |
|
Building Materials |
|
32.6 |
% |
|
|
32.0 |
% |
|
|
29.2 |
% |
|
|
30.6 |
% |
|
Building Envelope |
|
19.2 |
% |
|
|
22.1 |
% |
|
|
22.2 |
% |
|
|
22.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
(1) Acquisition and integration-related costs are those incurred for business combinations, including advisory, legal, valuation, and other professional fees. Certain warranty charges related to a pre-acquisition manufacturing issue are also included. |
|||||||||||||||
|
(2) Litigation-related costs include certain litigation settlements, environmental remediation, and legal-related consulting and professional fees that are not representative of expenses arising in the ordinary course of business. |
|||||||||||||||
|
(3) Loss on impairments consist of one-time charges on the Company’s investments and property, plant and equipment. |
|||||||||||||||
|
(4) Restructuring and other costs primarily include charges associated with non-core sites. |
|||||||||||||||
|
(5) Spin-off and separation-related costs notably include rebranding costs. |
|||||||||||||||
|
(6) Other non-operating (income) expense, net primarily consists of costs related to pension and other postretirement benefit plans and gains on proceeds from property and casualty insurance. |
|||||||||||||||
|
Amrize Ltd |
|
|
|
|
|
Reconciliation of Non-GAAP Financial Measures (Unaudited) |
|
|
|
|
|
Net Debt |
|
|
|
|
|
Adjusted EBITDA |
|
|
|
|
|
Net Leverage Ratio |
|
|
|
|
|
($ in millions, except ratio) |
|
|
|
|
|
|
|
|
As of December 31, 2025 |
|
|
Short-term borrowings |
|
$ |
— |
|
|
Current portion of long-term debt |
|
|
333 |
|
|
Long-term debt |
|
|
4,936 |
|
|
Gross Debt |
|
|
5,269 |
|
|
Less: Cash and cash equivalents |
|
|
1,922 |
|
|
Net Debt |
|
$ |
3,347 |
|
|
|
|
|
|
|
|
|
|
|
For the year ended (trailing twelve |
|
|
Net income |
|
$ |
1,182 |
|
|
Depreciation, depletion, accretion and amortization |
|
|
914 |
|
|
Interest expense, net |
|
|
413 |
|
|
Income tax expense |
|
|
326 |
|
|
EBITDA |
|
|
2,835 |
|
|
Acquisition and integration-related costs(1) |
|
|
64 |
|
|
Litigation-related costs(2) |
|
|
46 |
|
|
Loss on impairments(3) |
|
|
15 |
|
|
Restructuring and other costs(4) |
|
|
19 |
|
|
Spin-off and separation-related costs(5) |
|
|
43 |
|
|
Other non-operating income(6) |
|
|
(4 |
) |
|
Income from equity method investments |
|
|
(11 |
) |
|
Adjusted EBITDA |
|
$ |
3,007 |
|
|
|
|
|
|
|
|
(1) Acquisition and integration-related costs are those incurred for business combinations, including advisory, legal, valuation, and other professional fees. Certain warranty charges related to a pre-acquisition manufacturing issue are also included. |
||||
|
(2) Litigation-related costs include certain litigation settlements, environmental remediation, and legal-related consulting and professional fees that are not representative of expenses arising in the ordinary course of business. |
||||
|
(3) Loss on impairments consist of one-time charges on the Company’s investments and property, plant and equipment. |
||||
|
(4) Restructuring and other costs primarily include charges associated with non-core sites. |
||||
|
(5) Spin-off and separation-related costs notably include rebranding costs. |
||||
|
(6) Other non-operating income, net primarily consists of costs related to pension and other postretirement benefit plans and gains on proceeds from property and casualty insurance. |
||||
|
|
|
|
|
|
|
|
|
|
As of December 31, 2025 |
|
|
Net leverage ratio |
|
|
1.1x |
|
|
Amrize Ltd |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Reconciliation of Non-GAAP Financial Measures (Unaudited) |
|
|
|
|
|
|
|
|
|
||||||
|
Free Cash Flow |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Adjusted Diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
||||
|
($ in millions, except ratios and per share amounts) |
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
For the three months ended |
|
|
For the years ended |
||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Net cash provided by operating activities |
$ |
1,804 |
|
|
$ |
1,727 |
|
|
$ |
2,208 |
|
|
$ |
2,282 |
|
|
Capital expenditures, net(1) |
|
(148 |
) |
|
|
(56 |
) |
|
|
(745 |
) |
|
|
(549 |
) |
|
Free Cash Flow |
$ |
1,656 |
|
|
$ |
1,671 |
|
|
$ |
1,463 |
|
|
$ |
1,733 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
(1) Capital expenditures, net includes purchases of property, plant and equipment, proceeds from property and casualty insurance income, proceeds from land expropriation and proceeds from disposals of long-lived assets. |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
For the three months ended |
|
|
For the years ended |
||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Diluted EPS |
$ |
0.54 |
|
|
$ |
0.53 |
|
|
$ |
2.14 |
|
|
$ |
2.30 |
|
|
Acquisition and integration-related costs(1) |
|
0.04 |
|
|
|
0.02 |
|
|
|
0.09 |
|
|
|
0.06 |
|
|
Litigation-related costs(2) |
|
— |
|
|
|
0.01 |
|
|
|
0.06 |
|
|
|
0.02 |
|
|
Loss on impairments(3) |
|
0.02 |
|
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
Restructuring and other costs(4) |
|
0.01 |
|
|
|
— |
|
|
|
0.03 |
|
|
|
0.02 |
|
|
Spin-off and separation-related costs(5) |
|
0.01 |
|
|
|
0.01 |
|
|
|
0.06 |
|
|
|
0.04 |
|
|
Adjusted Diluted EPS |
$ |
0.62 |
|
|
$ |
0.57 |
|
|
$ |
2.40 |
|
|
$ |
2.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
(1) Acquisition and integration-related costs are those incurred for business combinations, including advisory, legal, valuation, and other professional fees. Certain warranty charges related to a pre-acquisition manufacturing issue are also included. |
|||||||||||||||
|
(2) Litigation-related costs include certain litigation settlements, environmental remediation, and legal-related consulting and professional fees that are not representative of expenses arising in the ordinary course of business. |
|||||||||||||||
|
(3) Loss on impairments consist of one-time charges on the Company’s investments and property, plant and equipment. |
|||||||||||||||
|
(4) Restructuring and other costs primarily include charges associated with non-core sites. |
|||||||||||||||
|
(5) Spin-off and separation-related costs notably include rebranding costs. |
|||||||||||||||
|
For the U.S. GAAP to Adjusted Diluted EPS reconciliation, adjusted items are shown net of tax in aggregate of $14 million and $7 million for the three months ended December 31, 2025 and 2024, respectively, and in aggregate of $44 million and $23 million for the years ended December 31, 2025 and 2024, respectively, based on applying the statutory tax rate for the jurisdictions in which the adjustment occurred or, by adjusting the tax effect to consider the impact of applying an annual effective tax rate on an interim basis. For purposes of reconciling adjusted diluted earnings per share with respect to taxes period-over-period, the Company utilizes a “rate approach” to highlight the impact of the adjusted tax rate. It is computed by multiplying the prior period adjusted rate by the current period adjusted income before taxes to determine the expected tax expense. Such expected tax expense is then compared to actual tax expense. Expected tax in excess of actual tax variance is favorable; actual tax in excess of expected tax variance is unfavorable. The variance divided by diluted shares outstanding at the end of the period yields the impact on earnings per share. Management believes the use of this measure best aids in explaining the impact of a changing tax rate. |
|||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260217470417/en/
Media Relations:[email protected]
Investor Relations:[email protected]
KEYWORDS: Illinois Europe Switzerland United States North America
INDUSTRY KEYWORDS: Engineering Chemicals/Plastics Manufacturing Other Construction & Property Residential Building & Real Estate Commercial Building & Real Estate Construction & Property Building Systems Other Natural Resources Forest Products Natural Resources Other Manufacturing Textiles Steel
MEDIA:
| Logo |
 |